This distinction matters when switching between peptides or when researchers accidentally apply semaglutide calculation logic to retatrutide, a common and potentially significant mistake
The warning concerns the named compounded iDexis products, not every authorised branded medicine containing these ingredients
In 2024, Novo generated roughly half its revenue from GLP-1s, while Ely Lilly earned $10.4 billion of its $15.6 billion total revenue from key products, illustrating that despite its broad pipeline, Eli Lilly is becoming more concentrated in its commercial performance of these key drugs
doi: 10.3892/ijo.22.4.765 43 MiyamotoMShimizuYOkadaKKashiiYHiguchiKWatanabeA
Obinutuzumab in patients with Sjogrens disease immunised against rituximab
Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells